Aberdeen Group plc Acquires New Holdings in Mereo BioPharma Group plc - Sponsored ADR $MREO
MarketBeat
Aberdeen Group plc bought a new position in Mereo BioPharma Group plc - Sponsored ADR (NASDAQ:MREO - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The fund bought 2,188,354 shares of the company's stock, valued at approximately $4,924,000. A
NASDAQ:MREO